Speaker illustration

Ms Prashanti Madhavapeddi

InCarda Therapeutics, Newark (United States of America)

Hysteresis between pharmacokinetics and changes in QRS complex duration following flecainide administered via oral inhalation or IV infusion

Event: ESC Congress 2018

Topic: Antiarrhythmic Pharmacotherapy

Session: Arrhythmia and cardio protection pharmacotherapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb